Unicycive Therapeutics, Inc.
UNCY • NASDAQ • Stock Fundamentals
Unicycive Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shalabh K. Gupta, with a market cap of $188.5M.
Market Cap$188.5M
Employees14.0
CEOShalabh K. Gupta
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Unicycive Therapeutics, Inc. FAQ
Common questions about Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. (UNCY) has a market capitalization of $188.5M and trades on NASDAQ.
Unicycive Therapeutics, Inc. has approximately 14 employees.